Anorexia, depression and dementia induced by dorzolamide eyedrops (Trusopt).
D000368:Aged; D000855:Anorexia / Q000139:chemically induced*; D002257:Carbonic Anhydrase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D003704:Dementia / Q000139:chemically induced*; D003863:Depression / Q000139:chemically induced*; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy; D006801:Humans; D007429:Intraocular Pressure; D009883:Ophthalmic Solutions / Q000009:adverse effects; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use; D013876:Thiophenes / Q000009:adverse effects* / Q000627:therapeutic use; D014792:Visual Acuity